PUBLISHER: DelveInsight | PRODUCT CODE: 1126008
PUBLISHER: DelveInsight | PRODUCT CODE: 1126008
DelveInsight's "Obesity - Epidemiology Forecast-2032" report delivers an in-depth understanding of the obesity, historical and forecasted epidemiology as well as the obesity trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Study Period: 2019-2032.
The DelveInsight's obesity epidemiology report gives a thorough understanding of obesity. Obesity is defined as an abnormal or excessive accumulation of fat or adipose tissue in the body that presents a risk to health. The body mass index (BMI) is used to define obesity, which is calculated as weight (kg)/height (m2). A person with a body mass index greater than or equal to 30 is considered obese (WHO, 2022a). It is the second most common cause of preventable death, which has its association with the risk of development of inflammatory components, directly and indirectly, related to cardiovascular disease, diabetes mellitus, respiratory problems, psychological issues, hypertension, obstructive sleep apnea, cancer, and hyperlipidemia. It imposes a significant public health epidemic that has progressively worsened over the past semi-centennial. An increase in obesity has been observed in children as well as adults of both genders and is prevalent in both developed and developing countries.
Compared to other chronic diseases, obesity results from an interaction between an individual's genetic predisposition to weight gain and environmental influences. Gene discovery in the field of weight regulation and obesity has identified several major single-gene effects resulting in severe and early-onset obesity, as well as many more minor genes with more variable effects on weight and fat distribution, including age-of-onset and severity.
The most visible sign of obesity can be derived from the magnitude of excess adipose tissue fat, which is measured by taking anthropometric measurements such as body mass index (BMI), waist circumference, and others.
Body mass index, also known as Quetelet index, is defined as a person's weight in kilograms divided by the square of his height in meters (kg/m2). For adults, a person is considered obese if they have BMI greater than or equal to 30. Whereas for children under 5 years of age, obesity is considered when weight-for-height is greater than three standard deviations above the WHO Child Growth Standards median. For children aged between 5-19 years of age, obesity is considered when weight-for-height is greater than two standard deviations above the WHO Growth Reference median.
Diagnosis of obesity involves proper evaluation of the weight status, which considers many factors and uses various tools and diagnostic tests, including body mass index (BMI), waist circumference measurement, physical exams, and lab tests to check for comorbidities.
The epidemiology section provides insights about the historical and current obesity patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides a historical as well as forecasted obesity epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
In the year 2021, the total prevalent cases of obesity in adults (>19years) were 182.22 million and in children (5-19 years) were 7.85 million in the 7MM which are expected to grow during the study period, i.e., 2019-2032.
The disease epidemiology covered in the report provides historical as well as forecasted obesity epidemiology [segmented as total prevalent cases of obesity, total obesity patients seeking help, total treated cases of obesity] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.
The epidemiology segment also provides the obesity epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
To keep up with the current obesity patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the obesity domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.